Literature DB >> 29369402

Impact of a new simplified disability scoring system for adult patients with localized scleroderma.

Naoko Okiyama1, Yoshihide Asano2, Yasuhito Hamaguchi3, Masatoshi Jinnin4, Sei-Ichiro Motegi5, Haruka Koizumi6, Minoru Hasegawa6, Osamu Ishikawa5, Shinichi Sato2, Kazuhiko Takehara3, Toshiyuki Yamamoto7, Manabu Fujimoto1, Hironobu Ihn4.   

Abstract

Localized scleroderma (LoS) involves dermal but not internal inflammation and fibrosis. Cosmetic changes often impact quality of life (QOL), however, impairment of activities of daily living (ADL) in LoS patients has not been investigated. To determine what factor(s) are associated with ADL in adult patients with LoS, we performed a retrospective observational study in 177 Japanese adult LoS patients using a novel LoS disability score based on Barthel's indices of ADL: feeding, bathing, grooming, dressing, bowels, bladder, toilet use, transfers, mobility and stairs. LoS disability scores increased in proportion to the number of affected body parts but were not correlated to age and duration of illness. The presence of leg lesions significantly impaired ADL of LoS patients compared with lesions on other body parts. Patients treated with systemic medications, who tended to have multiple lesions, presented higher LoS disability scores than those without systemic treatments. Our study proposes that physicians evaluate ADL, not only QOL, in LoS patients. Our findings using LoS disability scoring indicate that multiple affected body parts and leg lesions are risk factors for ADL impairment.
© 2018 Japanese Dermatological Association.

Entities:  

Keywords:  activities of daily living; legs; localized scleroderma; retrospective observational study; scoring system

Mesh:

Year:  2018        PMID: 29369402     DOI: 10.1111/1346-8138.14214

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  1 in total

1.  Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) adapted for use in adult patients: report from an initial validation study.

Authors:  Alina Skrzypek-Salamon; Anna Lis-Święty; Irmina Ranosz-Janicka; Ligia Brzezińska-Wcisło
Journal:  Health Qual Life Outcomes       Date:  2018-09-14       Impact factor: 3.186

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.